Cytokinetics may be counting down the days until the FDA decides whether to approve its cardiovascular drug aficamten. But, for a biotech planning to commercialize its first drug—and without Big ...

Cytokinetics is following in the footsteps of Bristol Myers Squibb as it prepares to try to wrest control of a heart disease market away from the Big Pharma. About a year after BMS backed the launch ...

Jennifer Simonson is a business journalist with a decade of experience covering entrepreneurship and small business. Drawing on her background as a founder of multiple startups, she writes for Forbes ...

If you find managing your email annoying, it might be time to switch to another client. Be more productive with one of the top email apps we've tested. I've been testing PC and mobile software for ...

A capable email marketing service is essential for sending targeted ads, newsletters, special offers, or surveys to your customers. We help you choose the best one for your business based on our ...

The Centenary Bridge upgrade targets one of SEQ’s worst choke points by expanding the river crossing from four to six lanes. The new northbound bridge has previously been flagged for completion in ...

James Chen, CMT is an expert trader, investment adviser, and global market strategist. Gordon Scott has been an active investor and technical analyst or 20+ years. He is a Chartered Market Technician ...